Philogen SpA (MIL:PHIL) FCF Yield % : 4.61 (As of Apr. 22, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Philogen SpA's Trailing 12-Month Free Cash Flow is €38.43 Mil, and Market Cap is €833.77 Mil. Therefore, Philogen SpA's FCF Yield % for today is 4.61%.

The historical rank and industry rank for Philogen SpA's FCF Yield % or its related term are showing as below:

MIL:PHIL' s FCF Yield % Range Over the Past 10 Years
Min: -4.97 Med: -1.51 Max: 5.44
Current: 4.61

During the past 5 years, the highest FCF Yield % of Philogen SpA was 5.44%. The lowest was -4.97%. And the median was -1.51%.

MIL:PHIL's FCF Yield % is ranked better than
94.26% of 1498 companies
in the Biotechnology industry
Industry Median: -15.235 vs MIL:PHIL: 4.61

Philogen SpA's FCF Margin % for the quarter that ended in Dec. 2024 was 68.25%.

Philogen SpA FCF Yield % Historical Data

The historical data trend for Philogen SpA's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA FCF Yield % Chart

Philogen SpA Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

-4.44

-1.61

-1.43

4.89

Philogen SpA Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Yield %	Get a 7-Day Free Trial					-4.09	2.62	-5.18	-2.81	12.71

Competitive Comparison of Philogen SpA's FCF Yield %

For the Biotechnology subindustry, Philogen SpA's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Philogen SpA's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Philogen SpA's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Philogen SpA FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Philogen SpA's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	38.43	/	786.474
	=	4.89%

Philogen SpA's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	49.967	*	2	/	786.474
	=	12.71%

Philogen SpA FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Philogen SpA FCF Yield % Related Terms

Thank you for viewing the detailed overview of Philogen SpA's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (MIL:PHIL) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

78Q:Germany

Address

Piazza La Lizza No. 7, Siena, ITA, 53100

Website

https://www.philogen.com

Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.